FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Lannett Niacin Extended-release Tablets Recall

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distrib…

Lannett Company Inc. · Seymour, IN

Risk level
Class II
Reported by FDA
Oct 29, 2025
Recall ID
D-0096-2026
Check your lot numberHow we source this data

Summary

Lannett recalled Niacin Extended-release Tablets starting Oct 10, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0096-2026 on Oct 29, 2025. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications

Product description

Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46

Lot numbers, UPCs & expiration codes

Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0096-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 10, 2025
FDA report date
Oct 29, 2025
Quantity
46,848 90-count bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Lannett Company Inc.

Original FDA data

Every field from FDA enforcement report D-0096-2026, exactly as published.

Show all FDA fields
City
Seymour
State
IN
Status
Ongoing
Country
United States
Event ID
97778
Address
1101 C Ave W
Code information
Lot, expiry: 21264027A, Exp 10/30/2025; 22266446A, Exp 12/31/2025; 22266901A, Exp 02/28/2026; 22267553A, 22267554A, Exp 03/31/2026; 22267555A, Exp 02/28/2026; 22267992A, Exp 04/30/2026; 22267993A, 22267994A, Exp 05/31/2026
Postal code
47274-3342
Report date
Oct 29, 2025
Product type
Drugs
Recall number
D-0096-2026
Classification
Class II
Recalling firm
Lannett Company Inc.
Product quantity
46,848 90-count bottles
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Niacin Extended-release Tablets, USP, 1,000 mg, Rx Only, 90 Tablets per bottle, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136. NDC: 62175-322-46
Distribution pattern
Nationwide in the USA
Recall initiation date
Oct 10, 2025
Initial firm notification
Letter
Center classification date
Oct 22, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0096-2026, published Oct 29, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls